- Report
- April 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 130 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- September 2021
- 40 Pages
China
From €2366EUR$2,600USD£2,029GBP
- Report
- August 2022
- 119 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2023
- 353 Pages
Global
From €8646EUR$9,500USD£7,412GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2503EUR$2,750USD£2,146GBP
- Report
- March 2024
- 105 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Anastrozole is a drug used to treat breast cancer in postmenopausal women. It is a type of aromatase inhibitor, which works by blocking the production of the hormone estrogen. This helps to slow or stop the growth of certain types of breast cancer cells that need estrogen to grow. Anastrozole is usually prescribed after surgery and other treatments, such as radiation, have been tried without success.
Anastrozole is available in tablet form and is taken once a day. Common side effects include hot flashes, joint pain, and nausea. It is important to discuss any potential side effects with a doctor before taking the medication.
Anastrozole is one of several drugs used to treat breast cancer. Other drugs used to treat breast cancer include tamoxifen, fulvestrant, and letrozole. Each drug has its own benefits and risks, so it is important to discuss the best treatment option with a doctor.
Some companies in the Anastrozole market include AstraZeneca, Pfizer, Novartis, and Mylan. Show Less Read more
